Genomic Location Articles & Analysis
9 news found
Details: Session: Artificial Intelligence in Drug Discovery Date and time: Thursday, May 20, 2021 from 1:30 – 2:00 p.m. EDT About Deep Genomics Deep Genomics is pioneering the application of artificial intelligence and machine learning to program the best RNA therapies for almost any gene in any genetic condition. ...
January 6, 2022. Deep Genomics, the leading AI RNA therapeutics company, today announced that its Founder and CEO, Brendan Frey, PhD, FRSC, will present at the 40th Annual J.P. ...
DNA methylation is established and maintained by DNA methyltransferases (DNMT1, DNMT3a, and DNMT3b). CD Genomics uses a mature high-throughput sequencing platform combined with epigenetics to provide a variety of biological information analysis services such as genome-wide epigenetic location analysis and gene expression regulation mechanism ...
Deep Genomics, the leading AI therapeutics company, welcomes Tal Zaks, M.D., Ph.D., to its Strategic Advisory Board, effective today. Deep Genomics uses AI and machine learning to program and prioritize transformational nucleotide-based therapeutics for genetic diseases. ...
” Since its founding in 2015, Deep Genomics has built a suite of predictive systems known as the AI Workbench. It has made billions of predictions across the entire human genome for millions of genetic variants and hundreds of millions of novel compounds. ...
” Since its founding in 2015, Deep Genomics has built a suite of predictive systems known as the AI Workbench, which has made billions of predictions across the entire human genome, for millions of genetic variants, and hundreds of millions of novel compounds. ...
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the appointment of Jeffrey Brown, Ph.D., Vice President, Preclinical Research. ...
” “Therapeutically re-engineering the human genome is the final frontier,” said Brendan Frey, founder and CEO of Deep Genomics. ...
FUSION GENOMICS Corporation is a molecular diagnostic company that develops clinical assays using next-generation sequencing technologies to characterize infectious disease agents of clinical and global importance. We are looking to hire a full-time Postdoctoral Fellow to join our team in an exciting and highly dynamic start-up environment. FUSION GENOMICS ...